Journal of Current Glaucoma Practice

Register      Login

VOLUME 9 , ISSUE 3 ( September-December, 2015 ) > List of Articles

Original Article

Pigment Dispersion Syndrome Progression to Pigmentary Glaucoma in a Latin American Population

Hector Fernando Gomez Goyeneche, Diana Patricia Hernandez-Mendieta, Diego Andres Rodriguez, Ana Irene Sepulveda, Jose Daniel Toledo

Keywords : Pigment dispersion syndrome, Pigmentary glaucoma, Progression,Intraocular pressure

Citation Information : Gomez Goyeneche HF, Hernandez-Mendieta DP, Rodriguez DA, Sepulveda AI, Toledo JD. Pigment Dispersion Syndrome Progression to Pigmentary Glaucoma in a Latin American Population. J Curr Glaucoma Pract 2015; 9 (3):69-72.

DOI: 10.5005/jp-journals-10008-1187

License: CC BY-NC 4.0

Published Online: 00-12-2015

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Objective: To determine the progression of pigment dispersion syndrome (PDS) into pigmentary glaucoma (PG) in a population at the Central Military Hospital in Bogotá, Colombia. Materials and methods: A retrospective study was conducted, based on a review of medical records of patients with PDS evaluated in the Glaucoma Clinic. Data were collected in a database in excel and subsequently analyzed with the software Statistical Package for the Social Sciences (SPSS), performing Chi-square test analysis and Spearman\'s rho test. Results: Forty-eight eyes of 24 patients were included. Forty-two percent were women and 58% were men. Pigmentation of the trabecular meshwork was the most frequent clinical sign (100%), followed by Krukenberg\'s spindle (91.7%), the least frequent were the iris concavity and iris heterochromia (4.2%), the average of the spherical equivalent was of - 1.33 (SD 2.07). The rate of conversion of PDS to PG was 37.5%, after an average follow-up of 50.7 months. Having an intraocular pressure (IOP) greater than 21 mm Hg was statistically the only significant risk factor for conversion. Conclusion: We found several differences in frequency and clinical signs in these patients in contrast to previous data, probably due to different racial characteristics. The rate of progression is similar to previous reports despite of heterogeneity of these. Having IOP > 21 mm Hg was the only risk factor associated with progression in this sample.


PDF Share
  1. Niyadurupola N, Broadway DC. Pigment dispersion syndrome and pigmentary glaucoma—a major review. Clin Experiment Ophthalmol 2008 Dec;36(9):868-882.
  2. Farrar SM, Shields MB, Miller KN, Stoup CM. Risk factors for the development and severity of glaucoma in the pigment dispersion syndrome. Am J Ophthalmol 1989 Sep 15;108(3):223-229.
  3. R ichter CU, Richardson TM, Grant WM. Pigmentary dispersion syndrome and pigmentary glaucoma: a prospective study of the natural history. Arch Ophthalmol 1986 Feb;104(2): 211-215.
  4. Scheie HG, Cameron JD. Pigment dispersion syndrome: a clinical study. Br J Ophthalmol 1981 Apr;65(4):264-269.
  5. Andersen JS, Pralea AM, DelBono EA, Haines JL, Gorin MB, Schuman JS, Mattox CG, Wiggs JL. A gene responsible for the pigment Hector Fernando Gomez Goyeneche et al dispersion syndrome maps to chromosome 7q35-q36. Arch Ophthalmol 1997 Mar;115(3):384-388.
  6. Zhou X, Li F, Kong L, Tomita H, Li C, Cao W. Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma. J Biol Chem 2005 Sep 2;280(35):31240-31248.
  7. John SW, Smith RS, Savinova OV, Hawes NL, Chang B, Turnbull D, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 1998 May;39(6):951-962.
  8. Chang B, Smith RS, Hawes NL, Anderson MG, Zabaleta A, Savinova O, et al. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet 1999 Apr;21(4):405-409.
  9. Orgül S, Hendrickson P, Flammer J. Anterior chamber depth and pigment dispersion syndrome. Am J Ophthalmol 1994 May 15;117(5):575-577.
  10. Davidson JA, Brubaker RF, Ilstrup DM. Dimensions of the anterior chamber in pigment dispersion syndrome. Arch Ophthalmol 1983 Jan;101(1):81-83.
  11. Karickhoff JR. Pigmentary dispersion syndrome and pigmentary glaucoma: a new mechanism concept, a new treatment, and a new technique. Ophthalmic Surg 1992 Apr;23(4):269-277.
  12. Potash SD, Tello C, Liebmann J, Ritch R. Ultrasound biomicroscopy in pigment dispersion syndrome. Ophthalmology 1994 Feb;101(2):332-339.
  13. Karickhoff JR. Reverse pupillary block in pigmentary glaucoma: follow-up and new developments. Ophthalmic Surg 1993 Aug;24(8):562-563.
  14. Sugar HS, Barbour FA. Pigmentary glaucoma: a rare clinical entity. Am J Ophthalmol 1949 Jan;32(1):90-92.
  15. Migliazzo CV, Shaffer RN, Nykin R, Magee S. Long-term analysis of pigmentary dispersion syndrome and pigmentary glaucoma. Ophthalmology 1986 Dec;93(12):1528-1536.
  16. Siddiqui Y, Ten Hulzen RD, Cameron JD, Hodge DO, Johnson DH. What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol 2003 Jun;135(6):794-799.
  17. Qing G, Wang N, Tang X, Zhang S, Chen H. Clinical characteristics of pigment dispersion syndrome in Chinese patients. Eye (Lond) 2009 Aug;23(8):1641-1646.
  18. Scott A, Kotecha A, Bunce C, Balidis M, Garway-Heath DF, Miller MH, Wormald R. YAG laser peripheral iridotomy for the prevention of pigment dispersion glaucoma a prospective, randomized and controlled trial. Ophthalmology 2011 Mar; 118(3):468-473.
  19. Gomez-Goyenche F, Sandra B, Patricia B. Iridotomy in PDS in a Hispanic population. Rev Soc Colombiana de Oftalmología 2001 Jun;34(2):69-72.
  20. Gandolfi SA, Ungaro N, Tardini MG, Ghirardini S, Carta A, Mora P. A 10-year follow-up to determine the effect of YAG laser iridotomy on the natural history of pigment dispersion syndrome: a randomized clinical trial. JAMA Ophthalmol 2014 Dec;132(12):1433-1438.
  21. Gomez-Goyenche F, Sandra B, Patricia B. Pigmentary glaucoma in a hispanic population. Invest Opthalmol Vis Sci 2003 May;44:167.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.